You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 727 Topline safety and efficacy update of SUPLEXA-101, a first-in-human, single agent study of SUPLEXA therapeutic cells in 28 patients with metastatic solid tumours

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
727 Topline safety and efficacy update of SUPLEXA-101, a first-in-human, single agent study of SUPLEXA therapeutic cells in 28 patients with metastatic solid tumours

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023220014
Dec 20235208
Jan 20242303
Feb 20241601
Mar 20244007
Apr 20243604
May 20245403
Jun 20244803
Jul 20249206
Aug 20246802
Sep 20242800
Oct 20247609
Nov 20249807
Dec 20244204
Jan 20257808
Feb 20251402
Mar 2025200
Apr 2025007
May 2025003
Jun 2025004
Total987095